Sensing HIV Protease and Its Inhibitor Using “Helical Epitope”—Imprinted Polymers

• Main Authors: Chien-Yu Chou, Chung-Yin Lin, Cheng-Hsin Wu, Dar-Fu Tai
• Format: Article
• Language: English
• Published: MDPI AG 2020-06-01
• Series: Sensors
• Subjects: molecularly imprinted polymers; quartz crystal microbalance; HIV protease; protease inhibitor; nelfinavir; helical epitope
• Online Access: https://www.mdpi.com/1424-8220/20/12/3592

A helical epitope-peptide (lle⁸⁵-Gly⁹⁴) was selected from the α-helix structure of the HIV protease (PR) as the template, which represents an intricate interplay between structure conformation and dimerization. The peptide template was mixed with water, trifluoroethanol (TFE), and acetonitrile (ACN) at a certain ratio to enlarge the helical conformation in the solution for the fabrication of helical epitope-mediated molecularly imprinted polymers (HEMIPs) on a quartz crystal microbalance (QCM) chip. The template molecules were then removed under equilibrium batch rebinding conditions involving 5% acetic acid/water. The resulting HEMIPs chip exhibited a high affinity toward template peptide HIV PR_85–94, His-tagged HIV PR, and HIV PR, with dissociation constants (K_d) as 160, 43.3, and 78.5 pM, respectively. The detection limit of the developed HIV PR_85–94 QCM sensor is 0.1 ng/mL. The HEMIPs chip exhibited a high affinity and selectivity to bind HIV PR and subsequently to an inhibitor of HIV PR (nelfinavir). The HIV PR binding site was properly oriented on the HEMIPs-chip to develop a HIV PR/HEMIPs chip, which can effectively bind nelfinavir to establish a sandwich assay. The nelfinavir then attached to the HIV PR/HEMIPs chip, which can be easily removed involving 0.8% acetic acid/water. Therefore, HIV PR/HEMIPs chip can be useful to screen for other HIV PR inhibitors. This technique may improve drug targeting for HIV therapy and also strengthen investigations into other virus assays.